These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38357740)
1. A Microfluidic Platform for Evaluating the Internalization of Liposome Drug Carriers in Tumor Spheroids. Yakavets I; Ayachit M; Kheiri S; Chen Z; Rakhshani F; McWhirter S; Young EWK; Walker GC; Kumacheva E ACS Appl Mater Interfaces; 2024 Feb; 16(8):9690-9701. PubMed ID: 38357740 [TBL] [Abstract][Full Text] [Related]
2. High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid cultures. Bourn MD; Batchelor DVB; Ingram N; McLaughlan JR; Coletta PL; Evans SD; Peyman SA J Control Release; 2020 Oct; 326():13-24. PubMed ID: 32562855 [TBL] [Abstract][Full Text] [Related]
3. Microfluidic preparation of drug-loaded PEGylated liposomes, and the impact of liposome size on tumour retention and penetration. Dong YD; Tchung E; Nowell C; Kaga S; Leong N; Mehta D; Kaminskas LM; Boyd BJ J Liposome Res; 2019 Mar; 29(1):1-9. PubMed ID: 29020849 [TBL] [Abstract][Full Text] [Related]
4. Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids. Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud AM; Sgouros G J Liposome Res; 2005; 15(1-2):15-27. PubMed ID: 16194925 [TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil). Tsukioka Y; Matsumura Y; Hamaguchi T; Koike H; Moriyasu F; Kakizoe T Jpn J Cancer Res; 2002 Oct; 93(10):1145-53. PubMed ID: 12417045 [TBL] [Abstract][Full Text] [Related]
6. Microfluidic arrays of dermal spheroids: a screening platform for active ingredients of skincare products. Chen Z; Kheiri S; Gevorkian A; Young EWK; Andre V; Deisenroth T; Kumacheva E Lab Chip; 2021 Oct; 21(20):3952-3962. PubMed ID: 34636823 [TBL] [Abstract][Full Text] [Related]
7. Microfluidic Arrays of Breast Tumor Spheroids for Drug Screening and Personalized Cancer Therapies. Prince E; Kheiri S; Wang Y; Xu F; Cruickshank J; Topolskaia V; Tao H; Young EWK; McGuigan AP; Cescon DW; Kumacheva E Adv Healthc Mater; 2022 Jan; 11(1):e2101085. PubMed ID: 34636180 [TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating corosolic acid liposome as a functional carrier for delivering chemotherapeutic drugs. Li X; Widjaya AS; Liu J; Liu X; Long Z; Jiang Y Acta Biomater; 2020 Apr; 106():301-313. PubMed ID: 32081779 [TBL] [Abstract][Full Text] [Related]
9. Microfluidic synthesis of multifunctional liposomes for tumour targeting. Ran R; Middelberg APJ; Zhao CX Colloids Surf B Biointerfaces; 2016 Dec; 148():402-410. PubMed ID: 27639490 [TBL] [Abstract][Full Text] [Related]
10. Microfluidic technique to measure intratumoral transport and calculate drug efficacy shows that binding is essential for doxorubicin and release hampers Doxil. Toley BJ; Tropeano Lovatt ZG; Harrington JL; Forbes NS Integr Biol (Camb); 2013 Sep; 5(9):1184-96. PubMed ID: 23860772 [TBL] [Abstract][Full Text] [Related]
11. Predicting diffusive transport of cationic liposomes in 3-dimensional tumor spheroids. Wientjes MG; Yeung BZ; Lu Z; Wientjes MG; Au JL J Control Release; 2014 Oct; 192():10-8. PubMed ID: 24995948 [TBL] [Abstract][Full Text] [Related]
12. Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers. Hood RR; Shao C; Omiatek DM; Vreeland WN; DeVoe DL Pharm Res; 2013 Jun; 30(6):1597-607. PubMed ID: 23386106 [TBL] [Abstract][Full Text] [Related]
13. Assessing Advantages and Drawbacks of Rapidly Generated Ultra-Large 3D Breast Cancer Spheroids: Studies with Chemotherapeutics and Nanoparticles. Holub AR; Huo A; Patel K; Thakore V; Chhibber P; Erogbogbo F Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575896 [TBL] [Abstract][Full Text] [Related]
14. A novel 3D breast-cancer-on-chip platform for therapeutic evaluation of drug delivery systems. Chen Y; Gao D; Wang Y; Lin S; Jiang Y Anal Chim Acta; 2018 Dec; 1036():97-106. PubMed ID: 30253842 [TBL] [Abstract][Full Text] [Related]
15. A Microfluidic Multisize Spheroid Array for Multiparametric Screening of Anticancer Drugs and Blood-Brain Barrier Transport Properties. Eilenberger C; Rothbauer M; Selinger F; Gerhartl A; Jordan C; Harasek M; Schädl B; Grillari J; Weghuber J; Neuhaus W; Küpcü S; Ertl P Adv Sci (Weinh); 2021 Jun; 8(11):e2004856. PubMed ID: 34105271 [TBL] [Abstract][Full Text] [Related]
16. Aggregation of polyethylene glycol polymers suppresses receptor-mediated endocytosis of PEGylated liposomes. Shen Z; Ye H; Kröger M; Li Y Nanoscale; 2018 Mar; 10(9):4545-4560. PubMed ID: 29461551 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation. Xu WH; Han M; Dong Q; Fu ZX; Diao YY; Liu H; Xu J; Jiang HL; Zhang SZ; Zheng S; Gao JQ; Wei QC Int J Nanomedicine; 2012; 7():2661-71. PubMed ID: 22679376 [TBL] [Abstract][Full Text] [Related]
18. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389 [TBL] [Abstract][Full Text] [Related]
19. Concave microwell array-mediated three-dimensional tumor model for screening anticancer drug-loaded nanoparticles. Kang A; Seo HI; Chung BG; Lee SH Nanomedicine; 2015 Jul; 11(5):1153-61. PubMed ID: 25752856 [TBL] [Abstract][Full Text] [Related]
20. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. Perche F; Patel NR; Torchilin VP J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]